Dental Practice Valuation Multiples: 2026 Benchmarks by Method, Specialty, and Buyer
From January through September 2026, the Patient Prism research team analyzed published data from six sources to find what dental practices sell for and why prices vary so widely. The sources were four M&A advisory firms, the ADA Health Policy Institute, and a national DSO buy-side survey. We compared valuation multiples across every basis buyers use: percent of collections, SDE, adjusted EBITDA, and revenue. We then broke the results down by practice size, specialty, operating profile, and buyer type. All figures are shown as ranges and reflect U.S. transactions in 2025 and 2026. All multiples in this report are industry benchmarks from third-party advisors and surveys, not Patient Prism results.
Dental Practice Valuation Multiples at a Glance
The figure below shows the full range of 2026 dental practice valuation multiples, sorted from highest to lowest.
Figure 1, Panel A: Earnings-Based Multiples
| Deal type or tier | Range |
| Platform, $5M+ EBITDA (select cases) | 10–12× EBITDA¹ |
| Platform (general) | 9–11× EBITDA¹ |
| Emerging platform, $3M to $5M EBITDA | 9–11× EBITDA¹ |
| Regional add-on, $1M to $3M EBITDA | 7–9× EBITDA¹ |
| DSO add-on (general) | 5–8× EBITDA¹ |
| Tuck-in, under $1M EBITDA | 5–7× EBITDA¹ |
| Private buyer | 4.0–6.5× SDE³ * |
*Different earnings basis. Not directly comparable.
Figure 1, Panel B: Revenue-Based Multiples
| Measure | Range |
| Institutional revenue multiple | ~1.0–1.8× revenue¹ |
| Private sale, full range | 60–95% of collections² |
| Private sale, most deals | 70–85% of collections² |
| SBA-financed individual buyer | 60–75% of collections³ |
Key takeaways
- The data shows multiples climb steadily with EBITDA size, from 5–7× for small practices to 10–12× for the largest platforms.¹
- Private sales are priced on collections or SDE, so they sit on a different scale than DSO and PE deals.³
Valuation Multiples by Method
The table below compares every basis buyers use to price a dental practice, along with who uses each one.
Table 1: Dental Practice Valuation Multiples by Method, 2026
| Valuation basis | Typical buyer | Low end | High end | Deal profile at this range |
| Percent of annual collections | Individual or associate dentist | 60%² | 95%² | Most deals land at 70–85%² |
| Multiple of SDE | Private buyer | 4.0׳ | 6.5׳ | Solo and two-doctor practices³ |
| Multiple of adjusted EBITDA (add-on) | DSO add-on buyer | 5×¹ | 8×¹ | 1–3 locations, stable but smaller EBITDA¹ |
| Multiple of adjusted EBITDA (platform) | PE-backed platform | 9×¹ | 11×; 10–12× select $5M+¹ | 5+ doctors, multi-site, established governance¹ |
| Multiple of revenue | DSO or PE | ~1.0×¹ | ~1.8×¹ | Institutional deals priced on EBITDA, shown as revenue¹ |
Key takeaways
- The data shows the multiple depends on who is buying. Private buyers price on collections or SDE. DSOs and PE firms price on adjusted EBITDA.¹ ³
- Most doctor-to-doctor sales land at 70–85% of annual collections.²
- Platform deals run 9–11× EBITDA, a few turns above DSO add-ons at 5–8×.¹
- Revenue multiples of about 1.0–1.8× are a byproduct of EBITDA pricing, not a separate valuation method.¹
The next question most readers have is why these numbers look so different. The table below explains what each basis actually measures.
Table 2: What Each Valuation Basis Measures
| Basis | What it measures | When it’s used | Why it doesn’t compare directly |
| Percent of collections | Price as a share of trailing annual collections² | Smaller private sales, SBA-financed buyers³ | Ignores profit; equal collections can hide very different margins |
| SDE | Earnings plus the owner’s full pay and personal expenses³ | Buyer will replace the owner in the chair³ | Larger earnings base, so the multiple is lower³ |
| Adjusted EBITDA | Earnings with owner pay reset to a market-rate dentist¹ ³ | DSO and institutional buyers³ | Smaller earnings base, so the multiple is higher³ |
| Revenue multiple | Enterprise value divided by revenue¹ | Cross-checking institutional deals¹ | Varies with margin, so it is not a pricing method on its own |
Key takeaways
- SDE and EBITDA measure different things. A 5× SDE offer and a 5× EBITDA offer are not the same price.³
- On the same practice, SDE can run well above adjusted EBITDA, because SDE keeps the owner’s full clinical pay in the earnings figure.³
- Practices crossing roughly $750K to $1M in adjusted earnings enter a zone where both buyer types compete and methods can be mismatched.³
- Percent of collections is a quick screen, not a valuation. It rewards revenue over profit.
Multiples by Practice Type
Specialty groups and their investors often ask how much more specialty practices sell for. The table below shows the premium buyers pay over a general practice of similar size.
Table 3: Specialty Premium Over General Dentistry at Similar Size
| Practice type | Premium over general dentistry | Why buyers pay it | Data confidence |
| General dentistry | Baseline: 5–11× by size tier, 10–12× select $5M+¹ | Hygiene-driven recurring revenue¹ | High |
| Orthodontics | +1 to 3 turns of EBITDA⁴ | Case complexity, favorable margins, referral synergies⁶ | Moderate |
| Oral and maxillofacial surgery | +1 to 3 turns of EBITDA⁴ | Strongest demand among specialties⁵ | Moderate |
| Pediatric dentistry | Premium reported, not quantified⁴ | Referral-network economics⁴ | Low (qualitative only) |
Key takeaways
- The data shows that orthodontics and oral surgery typically trade 1 to 3 turns above a general practice of similar size.⁴
- Oral surgery draws the strongest buyer demand of any specialty.⁵
- Pediatric practices earn a premium, but no primary source puts a number on it.⁴
- Primary advisors publish specialty value as a premium over general dentistry, not as a standalone range. Treat any page quoting a fixed “specialty multiple” with caution.
The table below shows how specialty and size combine at the top and bottom of the market.
Table 4: Highest vs. Lowest Multiple Profiles
| Profile | EBITDA tier | Expected multiple |
| Highest: multi-site specialty group (ortho or OMS) at platform scale | $5M+¹ | 10–12× base,¹ plus specialty premium⁴ |
| High: general dentistry platform | $3M to $5M¹ | 9–11×¹ |
| Mid: regional general dentistry add-on | $1M to $3M¹ | 7–9×¹ |
| Low: single-location general practice, owner-dependent | Under $1M¹ | 5–7×¹ |
| Lowest: solo practice below DSO engagement floor | Under $250K⁷ | Priced on collections or SDE³ |
Key takeaways
- Scale moves the multiple more than specialty does. A general group with $3M or more in EBITDA can outprice a small specialty practice.¹ ⁴
- Specialty and scale stack. Multi-site orthodontic and oral surgery groups sit at the top of the market.¹ ⁴
- Below roughly $250K in adjusted EBITDA, the DSO buyer pool mostly disappears.⁷
What Drives the Multiple
Two practices with the same EBITDA can receive very different offers. The table below shows which factors move the multiple up or down.
Table 5: Effect of Key Factors on the Multiple
| Factor | Raises the multiple | Lowers the multiple | Size of effect |
| EBITDA scale | $3M+ EBITDA, multi-location density¹ | Under $1M, limited infrastructure¹ | Moves a practice across tiers, from 5–7× up to 9–11×¹ |
| Provider concentration | Production spread across providers³ | Owner produces 90%+ of revenue³ | 10–20% valuation reduction (advisor estimate)³ |
| Payer mix | Commercial or fee-for-service above 50%³ | Medicaid above 40% of revenue³ | 1–2× EBITDA discount (advisor estimate)³ |
| Hygiene program | Hygiene at 25–33% of collections, recall above 85%³ | Hygiene below 20%, declining recall³ | Supports top vs. bottom of range³ |
| Management and systems | SOPs, KPI dashboards, centralized scheduling¹ | Owner runs all operations³ | 1–3× added (advisor estimate)³ |
| Financial trend | Stable or growing results⁸ | Softening during the sale process⁸ | Top-3 reason DSOs walk away⁸ |
Key takeaways
- The data shows provider risk is now a primary decision driver.⁸ Heavy reliance on the owner-doctor can cut value by 10–20%.³
- Hygiene strength and recall adherence are core to how buyers underwrite recurring EBITDA.¹
- Buyers reward operating systems: documented processes, KPI dashboards, and centralized scheduling.¹
- A downward trend during diligence can end a deal.⁸ Stable results through the sale process protect the multiple.
- Effect sizes marked “advisor estimate” come from one sell-side firm and should be read as directional.
Practice structure is one of the few drivers leadership can change on purpose. The table below compares solo, single-location, and multi-location groups.
Table 6: Solo vs. Group; Single vs. Multi-Location
| Structure | Typical buyer | Earnings basis | Range |
| Solo or two-doctor practice | Individual dentist³ | SDE³ | 4.0–6.5× SDE³ |
| Practice with 1–3 locations | DSO add-on¹ | Adjusted EBITDA¹ | 5–8×¹ |
| Multi-location group, $1M to $5M EBITDA | Regional DSO or emerging platform¹ | Adjusted EBITDA¹ | 7–9× at $1M to $3M; 9–11× at $3M to $5M¹ |
| Multi-site platform, 5+ doctors | PE sponsor¹ | Adjusted EBITDA¹ | 9–11×¹ |
Key takeaways
- Moving from one location to several is the clearest path to a higher multiple.¹
- Groups with 5+ doctors reach platform pricing that solo practices cannot.¹
- The solo buyer pool is shrinking. Only 15% of dentists less than 10 years out of school were in solo practice in 2024, compared to 48% of dentists at least 25 years out.⁹
DSO vs. Private Sale
For larger practices, the biggest pricing choice is who to sell to. The table below compares multiples and offer structures by buyer type.
Table 7: Multiples by Buyer Type
| Buyer | Earnings basis | Range | How the offer is paid |
| Individual or associate dentist | Collections or SDE² ³ | 60–95% of collections (most 70–85%);² 4.0–6.5× SDE³ | Typically SBA-financed³ |
| Regional DSO (add-on) | Adjusted EBITDA¹ | 5–8×¹ | Cash plus equity rollover, earnouts, or escrow holdbacks³ |
| PE-backed platform | Adjusted EBITDA¹ | 9–11×¹ | Cash plus joint-venture, HoldCo, or hybrid equity⁸ |
Key takeaways
- The data shows DSOs often pay more for practices large enough to attract them. One advisor estimates the gap at about 30% for a mid-sized practice.³
- The headline multiple is only part of the offer. Equity rollover and earnouts can change what a seller actually receives.³ ⁸
- Offers vary more than ever. The spread between a best offer and a middle offer has never been wider.⁸
- About 16% of U.S. dentists are now affiliated with a DSO, and the institutional buyer pool keeps growing.¹⁰
The DSO premium depends heavily on size. The table below shows the EBITDA levels where buyer type and pricing shift.
Table 8: Deal-Size Thresholds Where DSO Premiums Kick In
| Adjusted EBITDA | Who’s buying | Multiple | What changes at this tier |
| Under $250K | Mostly individual dentists⁷ | Collections or SDE³ | DSOs rarely engage⁷ |
| $250K to $1M | Small DSO tuck-ins, individual buyers¹ | 5–7×¹ | Both buyer types in play; SDE to EBITDA shift begins near $750K³ |
| $1M to $3M | Regional DSO add-ons¹ | 7–9×¹ | Strong hygiene mix, early operating maturity¹ |
| $3M to $5M | Emerging platforms¹ | 9–11×¹ | Multi-location stability, centralized functions¹ |
| $5M+ | Platform buyers¹ | 10–12× (select cases)¹ | Professional management, scalable footprint¹ |
Key takeaways
- Regional DSO add-on pricing begins at about $1M in adjusted EBITDA and builds with each tier.¹
- Crossing from the $1M to $3M tier into the $3M to $5M tier adds about 2 turns.¹
- Timing matters for buyers. 78% of surveyed DSOs expect recaps within 12 to 36 months, which drives demand for high-quality EBITDA.⁸
- The same survey ranked M&A activity and organic same-store sales as top DSO priorities for 2026.⁸ Growth inside existing locations lifts both EBITDA and the multiple it earns.
Dental Practice Valuation Multiples: The Multiple Is Earned Before the Sale
The data points to one clear pattern. Headline multiples have held steady, but the gap between the best and middle offers has grown.¹ ⁸ Buyers now pay for proof: stable providers, strong hygiene recall, steady patient volume, and results that hold up in diligence.¹ ⁸ For multi-location operators, that makes same-store growth a valuation lever, not just an operating goal. Most DSOs expect a recap within three years and rank organic same-store sales as a top priority.⁸ A group that books more of the patients already calling, texting, filling out web forms, and booking online grows EBITDA without adding a location. Most booking gaps are operational: staffing alignment, scheduling bottlenecks, and performance differences between locations.
This is where understanding what happened in each patient interaction changes what happens next. Patient Prism’s Revenue Activation System shows multi-location leaders where appointments are lost across every touchpoint and routes those opportunities back to their teams. Healthcare networks using Patient Prism typically see a 15 to 30% increase in same-store appointment volume within 90 days, depending on adoption.
See where your practices are missing appointments before a buyer’s diligence team does. Get a demo with Patient Prism
References
- FOCUS Investment Banking. Dental Practice EBITDA Multiples 2026. April 27, 2026. https://focusib.com/insights/article/dental-practice-ebitda-2026/
- DDSmatch. How to Value a Dental Practice Before Selling. 2025. https://cowy.ddsmatch.com/2025/06/06/how-to-value-a-dental-office-before-selling/
- McLerran & Associates. How Are Dental Practice Valuation Multiples Calculated? August 11, 2026. https://dentaltransitions.com/articles/dental-practice-valuation-multiples-2026/
- McLerran & Associates. DSO Dental Practice Valuation Multiples: 2026 Guide. 2026. https://dentaltransitions.com/articles/dso-dental-valuation-multiples-2026/
- McLerran & Associates. 2026 DSO Practice Multiples & EBITDA Valuation Guide. 2026. https://dentaltransitions.com/articles/average-dso-practice-multiples-2026/
- VMG Health. Dental Service Organizations M&A in 2026: Transaction, Valuation & Compliance Priorities. January 29, 2026. https://vmghealth.com/insights/blog/dental-service-organizations-ma-in-2026-transaction-valuation-compliance-priorities-for-investors-executive-leadership/
- McLerran & Associates. Dental Practice Sale Multiples: 2026 Valuation Guide. August 2026. https://dentaltransitions.com/articles/dental-practice-sale-multiples-2026/
- TUSK Practice Sales. Q1 2026 Dental M&A Market Report (PR Newswire). January 16, 2026. https://www.prnewswire.com/news-releases/tusk-practice-sales-releases-2026-dental-ma-market-report-highlighting-key-updates-for-practice-owners-302663413.html
- ADA Health Policy Institute. Practice Ownership Trends in Dentistry: A New Look at Old Data. 2025. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/research/hpi/practice_ownership_trends_dentistry_new_look_old_data.pdf
- ADA Health Policy Institute. Dental Practice Research. 2024 data. https://www.ada.org/resources/research/health-policy-institute/dental-practice-research